Skip to main content
Clinical Trials/NCT01813968
NCT01813968
Completed
Not Applicable

Ischemic Postconditioning in Cardiac Surgery

Oslo University Hospital1 site in 1 country209 target enrollmentJanuary 2013
ConditionsCardiac Surgery

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiac Surgery
Sponsor
Oslo University Hospital
Enrollment
209
Locations
1
Primary Endpoint
Change in cardiac index between the groups during the first postoperative day
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Ischemic postconditioning by repetitive cycles of reperfusion and ischemia has been proven both in animal models and in humans. This study aims to investigate the effect of ischemic postconditioning on postoperative hemodynamic function in a standard heart surgery patient population.

Detailed Description

Ischemic postconditioning is studied using cardiopulmonary bypass (CPB) and moderate hypothermia (32-34°C) in a patient population undergoing surgery of the aortic valve (repair/replacement ) or the ascending aorta. Postconditioning is applied by introducing reperfusion/ischemia via the cardioplegia line while the aorta is still cross-clamped thereby preventing the risk of additional neurological complications. All patients \> 20 years eligible for aortic or aortic valve surgery and not affected by exclusion criteria, will be included. The study is carried out as a randomised controlled multicenter study including 5-6 heart surgery centers.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
June 5, 2018
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Oslo University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Mari-Liis Kaljusto

MD, PhD

Oslo University Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing elective surgery of the ascending aorta or the aortic valve

Exclusion Criteria

  • Coronary artery disease requiring bypass surgery
  • Tricuspid valve surgery
  • Mitral valve surgery
  • Atrial fibrillation (permanent or paroxysmal with or without concomitant ablation procedure)
  • Patients on per oral or parenteral steroid therapy (inhalational steroids are allowed)
  • Patients with autoimmune diseases
  • "Redo" operations
  • Active endocarditis (ongoing antibiotic therapy)
  • On the discretion of the operating surgeon or anaesthesiologist

Outcomes

Primary Outcomes

Change in cardiac index between the groups during the first postoperative day

Time Frame: The first postoperative day: measurements at 2, 8 and 18 hrs postoperatively

Cardiac index is measured by a Swan-Ganz catheter inserted preoperatively

Study Sites (1)

Loading locations...

Similar Trials